Zacks Investment Research on MSN
Quest Diagnostics (DGX) upgraded to buy: Here's why
Quest Diagnostics (DGX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
SECAUCUS, N.J., June 23, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2025 financial ...
Represents estimated pre-tax charges of $41 million primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business.
Represents estimated pre-tax charges of $37 million primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business.
Zacks Investment Research on MSN
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now?
Quest Diagnostics DGX is well-poised to grow in the coming quarters, supported by its value-creating, strategic acquisitions. The company’s Advanced Diagnostics offerings deliver and scale innovative ...
SECAUCUS, N.J., Sept. 25, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report third quarter 2025 financial ...
Here is how Quest Diagnostics (DGX) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.
Florida Gov. Ron DeSantis on Tuesday immediately severed ties with Quest Diagnostics Labs after the clinical laboratory company “dumped” nearly 75,000 months-old COVID-19 tests, skewing the state’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results